Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Thomas

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Proteome Research|February 1, 2011
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation studyMohamed I F Shariff, Asmaa I Gomaa, I Jane Cox, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Genetic factors in the pathogenesis of cholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Jason H Wong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 26, 2011
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinomaMohamed S Hashim Abdalla, Simon D Taylor-Robinson, Amar W Sharif, et al.
Clinical Science (London, England : 1979)|August 13, 2008
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueJeremy F L Cobbold, Quentin M Anstee, Robert D Goldin, et al.
Neurology|February 22, 2013
Modulation of neural activation following treatment of hepatic encephalopathyMark J W McPhail, Robert Leech, Vijay P B Grover, et al.
Journal of Hepatology|December 3, 2014
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolismSimon H Bridge, David A Sheridan, Daniel J Felmlee, et al.
Journal of Clinical and Experimental Hepatology|April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for CholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2006
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistenceAngela J Frodsham, Lyna Zhang, Uga Dumpis, et al.
Nature Communications|November 28, 2013
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibitionQuentin M Anstee, Susanne Knapp, Edward P Maguire, et al.
Nature Genetics|October 18, 2011
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasmaJohn C Chambers, Weihua Zhang, Joban Sehmi, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Proteome Research|February 1, 2011
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation studyMohamed I F Shariff, Asmaa I Gomaa, I Jane Cox, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Genetic factors in the pathogenesis of cholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Jason H Wong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 26, 2011
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinomaMohamed S Hashim Abdalla, Simon D Taylor-Robinson, Amar W Sharif, et al.
Clinical Science (London, England : 1979)|August 13, 2008
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueJeremy F L Cobbold, Quentin M Anstee, Robert D Goldin, et al.
Neurology|February 22, 2013
Modulation of neural activation following treatment of hepatic encephalopathyMark J W McPhail, Robert Leech, Vijay P B Grover, et al.
Journal of Hepatology|December 3, 2014
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolismSimon H Bridge, David A Sheridan, Daniel J Felmlee, et al.
Journal of Clinical and Experimental Hepatology|April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for CholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2006
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistenceAngela J Frodsham, Lyna Zhang, Uga Dumpis, et al.
Nature Communications|November 28, 2013
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibitionQuentin M Anstee, Susanne Knapp, Edward P Maguire, et al.
Nature Genetics|October 18, 2011
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasmaJohn C Chambers, Weihua Zhang, Joban Sehmi, et al.
Pageof 7